SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-18-000295
Filing Date
2018-03-12
Accepted
2018-03-09 20:38:46
Documents
6
Period of Report
2018-03-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ON FORM 8-K f8k030918_8k.htm 8-K 22941
2 EXHIBIT 1.1 UNDERWRITING AGREEMENT f8k030918_ex1z1.htm EX-1.1 165750
3 EXHIBIT 5.1 LEGAL OPINION AND CONSENT f8k030918_ex5z1.htm EX-5.1 7832
4 EXHIBIT 99.1 PRESS RELEASE ISSUED MARCH 8, 2018 f8k030918_ex99z1.htm EX-99.1 12812
5 EXHIBIT 99.2 PRESS RELEASE ISSUED MARCH 9, 2018 f8k030918_ex99z2.htm EX-99.2 12351
6 IMAGE f8k030918_ex5z11.jpg GRAPHIC 81611
  Complete submission text file 0001078782-18-000295.txt   334882
Mailing Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208
Business Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 18681704
SIC: 2835 In Vitro & In Vivo Diagnostic Substances